Methods for treating brain cancer using il-13r alpha 2 peptide-based compositions
US10874730B2 · kind B2 · utility
1Cited by
13References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 28, 2015 |
| Grant date | Dec 29, 2020 |
| Priority date | — |
| Expiry date | May 28, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2239/47
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are interleukin-13 receptor α2 peptide-based brain cancer vaccines and methods for treating and vaccinating against brain cancer comprising administering to patients in need thereof interleukin-13 receptor α2 peptide-based brain cancer vaccines. Also provided herein are regimens comprising interleukin-13 receptor α2 peptides and at least one additional peptide and/or immunostimulant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.